The study of a large European cohort showed that MR-proADM is an independent predictor of mortality in patients with chronic heart failure, and assessment of this biomarker adds prognostic information to N-terminal pro-B-type natriuretic peptide (NT-proBNP) [27]. This evidence concerns the gene NPPB and congestive heart failure.